A meta-analysis of 28 studies and 726 ASD patients found intranasal oxytocin had beneficial effects on social functioning but not on non-social symptoms, supporting it as a targeted treatment for core social impairments.
28 studies, 726 patientsThe largest meta-analysis of oxytocin for ASD finds a genuine benefit for social functioning — the core deficit that defines autism spectrum disorder
What the researchers found
Meta-analysis of 28 studies (N=726 ASD patients) found oxytocin had beneficial effects on social functioning but no strong evidence for improvement in non-social domains. Multilevel meta-analytic model used.
Why it matters
Social impairment is the core disability of ASD with no approved pharmacological treatment. This meta-analysis provides the strongest evidence to date that oxytocin specifically addresses this deficit, supporting its development as a targeted ASD therapy.
The numbers in context
28 studies; 726 ASD patients; improved social functioning; no non-social improvement; multilevel model
How the study worked
Systematic literature search. 28 studies included: randomized controlled trials, single/double-blind, open-label, and single-arm studies. 726 ASD patients total. Multilevel meta-analytic model to account for study heterogeneity.
Who was studied
Patients with autism spectrum disorder
What this study cannot tell us
Included both controlled and uncontrolled studies (though analyzed separately). High heterogeneity between studies. Varied dosing, duration, and outcome measures. Many studies were small. Effect sizes were modest.
How to read the evidence
Moderate-to-high evidence: meta-analysis with substantial number of studies, but limited by including heterogeneous study designs and predominantly small individual studies.
When this study was published
Published 2021. Oxytocin ASD research continues with larger, more rigorous clinical trials now underway.
The bigger picture
This meta-analysis positions oxytocin as the most evidence-backed pharmacological approach to the core social deficits of ASD. While individual studies have been mixed, the pooled data supports a real effect on social functioning.
Questions still open
- What dose and duration of oxytocin provides optimal social functioning improvement?
- Are certain ASD subgroups more likely to respond to oxytocin?
- Could sustained oxytocin treatment produce lasting social skill improvements?
Common questions
Does oxytocin help with autism?
Is oxytocin approved for autism treatment?
Read the original research
Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis.
Neuroscience and biobehavioral reviews, 122, 18-27
Citation
Huang, Yi; Huang, Xin; Ebstein, Richard P; Yu, Rongjun. (2021). Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis.. Neuroscience and biobehavioral reviews, 122, 18-27. https://doi.org/10.1016/j.neubiorev.2020.12.028